The future of CpG immunotherapy in cancer

Immunotherapy. 2013 Jan;5(1):1-3. doi: 10.2217/imt.12.148.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunotherapy / trends*
  • Nanoparticles / administration & dosage
  • Nanoparticles / therapeutic use
  • Neoplasms / therapy*
  • Oligodeoxyribonucleotides / administration & dosage
  • Oligodeoxyribonucleotides / classification
  • Oligodeoxyribonucleotides / therapeutic use*

Substances

  • CPG-oligonucleotide
  • Oligodeoxyribonucleotides